Influenza A virus H5N1 vaccine (CSL)

甲型流感病毒H5N1疫苗

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza A virus H5N1 vaccine (CSL)
Drug Alias NameH5N1 aluminium pandemic influenza vaccine (CSL)Avian influenza (bird flu) virus vaccine (CSL)H5N1 pandemic influenza vaccine (CSL)PanvaxCSL-401
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaN/A
Original Approved Country/TerritoryAustralia
Original Approved Date2008/06/17
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCsl Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCsl Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB01
Related LinksWikipediaKEGG